Florida,January19, 2018: The metabolomics market is projected to cross USD 2.0 Billion in the given forecasted period. North America contributed up to 45% of market share making it a market leader in metabolomics market. Europe is second largest market with up to 39% of the market share. Asia-Pacific will grow at remarkable CAGR i.e. 24% during the forecast period. Increasing penetration of pharmaceutical products is stimulating the APAC market.
Metabolomics is scientific term in which technical study of metabolites which is small molecules, biological cell, biofluids, tissue and organs. Metabolomics is also used to explain rising skill of measurement and study of metabolites like sugar & fat within the cell of organs by definite period and in definite situation. Metabolomics is having the common characteristics with computer science technology, mathematics, chemistry and biology. Metabolomics is important to medical doctor for the reason that it can guide to progress in the finding and treatments of person diseases. Analytical equipments and different software are very important object in metabolomics field.
The scope of the report includes a detailed study of global and regional markets for various types of metabolomics with the reasons given for variations in the growth of the industry in certain regions.
Browser Full Report @: https://www.marketresearchengine.com/reportdetails/metabolomics-market
This report provides:
1) An overview of the global market for metabolomics and related technologies.
2) Analyses of global market trends, with data from 2013, estimates for 2014 and 2015, and projections of compound annual growth rates (CAGRs) through 2020.
3) Identifications of new market opportunities and targeted promotional plans for metabolomics.
4) Discussion of research and development, and the demand for new products and new applications.
5) Comprehensive company profiles of major players in the industry.
The major driving factors of metabolomics market are as follows:
o Rising research funding and administration support drives the market growth.
o Use in biotechnology and pharmaceutical area spur the metabolomics research.
o Growing requirement of personalized medication within healthcare industry.
o Increasing requirement for toxicity equipment.
The restraints factors of metabolomics market are as follows:
o Data examination and data processing.
o Low acceptance rate.
The report covers detailed competitive outlook including the market share and company profiles of the key participants operating in the global market. Key players profiled in the report include:
- Thermo Fisher Scientific Inc.
• Danaher Corporation
• Waters Corporation
• Agilent Technologies
• Metabolon, Inc.
• Shimadzu Corporation
• Bruker Corporation
• Biocrates Life Sciences AG.
Company profile includes assign such as company summary, financial summary, business strategy and planning, SWOT analysis and current developments.
Request Sample Report: https://www.marketresearchengine.com/reportdetails/metabolomics-market
Table of Contents
2 Research Methodology
3 Executive Summary
4 Premium Insights
5 Market Overview
6 Industry Insights
7 Technology Investment Potential
8 Global Metabolomics Market, By Product and Service
9 Global Metabolomics Market, By Application
9.2 Biomarker Discovery
9.3 Drug Discovery
9.4 Toxicology Testing
9.6 Functional Genomics
9.7 Personalized Medicine
9.8 Other Applications
10 Global Metabolomics Market, By Indication
10.3 Cardiovascular Disorders
10.4 Neurological Disorders
10.5 Inborn Errors of Metabolism
10.6 Other Indications
11 Global Metabolomics Market, By Region
12 Competitive Landscape
13 Company Profiles
13.2 Thermo Fisher Scientific Inc.
13.3 Agilent Technologies, Inc.
13.4 Waters Corporation
13.5 Danaher Corporation
13.6 Shimadzu Corporation
13.7 Biocrates Life Sciences AG
13.8 Bio-Rad Laboratories, Inc.
13.9 Bruker Corporation
13.10 Human Metabolome Technologies, Inc.
13.11 Leco Corporation
13.12 Metabolon, Inc.
Company Name: Market Research Engine
Contact Person: John Bay
Country: United States